Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Budesonide nasal spray for allergic rhinitis and lower airway inflammation
ChiCTR-TRC-13004022Phase 4Completed
- Sponsor
- Jinling Hospital
- Start
- Nov 2012
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of budesonide in allergic rhinitis (AR) (2 arms), sponsored by Jinling Hospital. Primary endpoints: Eosinophils in nasal lavage, Eosinophils in induced sputum and 5 more. Started Nov 2012; status: completed.
02
Drugs
budesonide
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on ChiCTR-TRC-13004022.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-13004022.